S Christine Yoder

Title: S Christine Yoder: Innovator in Neosporosis Research

Introduction

S Christine Yoder, based in Salem, CT, is a prominent inventor known for his significant contributions to the field of biotechnology and medicine. With a focus on innovative solutions for combating infectious diseases, Yoder has made strides in research aimed at developing effective vaccines and diagnostic tools.

Latest Patents

Yoder holds a patent for "DNA encoding neospora dihydrofolate reductase-thymidylate synthase". This invention revolves around isolated polynucleotide molecules that comprise a nucleotide sequence encoding the DHFR-TS protein of Neospora. These polynucleotide molecules are instrumental in preparing modified live vaccines against neosporosis and serve as valuable diagnostic reagents. The invention also encompasses cloning and expression vectors, transformed host cells, purified DHFR-TS proteins, peptide fragments, genetic constructs for targeted gene deletion, and vaccine compositions.

Career Highlights

S Christine Yoder’s career is marked by his association with Pfizer Corporation, where he has been able to leverage his expertise in biotechnology to develop pioneering solutions for public health. His innovative approach and commitment to research have garnered recognition within the scientific community.

Collaborations

Throughout his career, Yoder has collaborated with notable colleagues, including B Rajendra Krishnan and Becky A Durtschi. These partnerships have played a critical role in fostering a collaborative environment that spurs creativity and innovation in addressing complex health challenges.

Conclusion

S Christine Yoder stands out as an influential inventor whose work has the potential to impact the fight against neosporosis significantly. His innovative patents and collaborative efforts exemplify the drive for advancements in medicine and public health, solidifying his position as a valuable contributor to the field of biotechnology.